SSA
GNLX icon

Schonfeld Strategic Advisors’s Genelux GNLX Stock Holding History

Schonfeld Strategic Advisors’s Portfolio GNLX Stock Details GNLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-13,200
Closed -$25.7K – 2177
2024
Q2 		$25.7K Buy
+13,200
New +$44.9K ﹤0.01% 1993

Other funds holding GNLX

WDC
Woodward Diversified Capital Bakersfield, California $227M AUM 40.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PWM
Provident Wealth Management Brentwood, Tennessee $331M AUM 15.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Schonfeld Strategic Advisors's GNLX Position: Q3 2024 in Review

Schonfeld Strategic Advisors sold out of Genelux (GNLX) in Q3 2024, closing a stake of 13,200 shares — an estimated $25.7K sold.

Schonfeld Strategic Advisors first reported a position in GNLX in Q2 2024 and held it in 1 quarter. The position peaked at $25.7K in Q2 2024. 57 funds tracked by Wall St. Rank hold GNLX as of Q3 2024.

  • Schonfeld Strategic Advisors reported no remaining Genelux position as of Q3 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 13,200 Genelux shares in Q3 2024, an estimated $25.7K.
  • Schonfeld Strategic Advisors first reported a position in Genelux in Q2 2024 and held it in 1 quarter.
  • Schonfeld Strategic Advisors's Genelux position peaked at $25.7K in Q2 2024.
  • 57 funds tracked by Wall St. Rank held Genelux as of Q3 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.